Antidote for acetaminophen poisoning: N-acetylcysteine.
10.5124/jkma.2013.56.12.1067
- Author:
Byeong Jo CHUN
1
;
Jeong Mi MOON
;
Seung Ho KIM
Author Information
1. Department of Emergency Medicine, Chonnam National University School of Medicine, Gwangju, Korea.
- Publication Type:Original Article
- Keywords:
Acetaminophen;
Hepatotoxicity;
Antidotes;
Acetylcysteine;
Anaphylactoid reaction
- MeSH:
Acetaminophen*;
Acetylcysteine*;
Adult;
Antidotes;
Asthma;
Benzoquinones;
Bronchial Spasm;
Cell Death;
Exanthema;
Flushing;
Glutathione;
Hemodynamics;
Hepatocytes;
Humans;
Hypersensitivity;
Imines;
Liver Failure;
Liver Failure, Acute;
Necrosis;
Poisoning*
- From:Journal of the Korean Medical Association
2013;56(12):1067-1075
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
N-acetylcysteine (NAC) is widely recognized as the antidote of choice for acetaminophen overdose. Acetaminophen is a commonly used analgesic and antipyretic agent, and its use is one of the most common causes of poisoning worldwide. Acetaminophen toxicity may occur acutely when supratherapeutic amounts are ingested purposefully or unintentionally. Liver failure may occur in severe toxicity. However, if treated early, patients with acetaminophen poisoning generally recover uneventfully. Acetaminophen is metabolized to N-acetyl-p-benzoquinone imine (NAPQI), which is detoxified by conjugation with glutathione. In overdose, hepatic stores of glutathione are depleted and NAPQI binding to hepatocytes induces cell death and hepatic necrosis. NAC replenishes hepatic glutathione and may also act as a glutathione substitute, combining directly with the toxic metabolite. Intravenous NAC is indicated in patients who present with a history of acetaminophen overdose within the previous 8 to 10 hours, patients unable to tolerate oral NAC, and patients who present with evidence of fulminant hepatic failure. However, caution should be used in patients who have experienced previous hypersensitivity or anaphylactoid reactions to intravenous NAC, as well as in patients with asthma. The most common anaphylactoid reactions include rash, flushing, and bronchospasm. Adults should receive 150 mg/kg administered for 45 minutes, followed by 50 mg/kg administered for 4 hours, followed by 100 mg/kg administered for 16 hours. The total dose is 300 mg/kg delivered over 21 hours. Additionally, caution should always be used when intravenous NAC is prescribed and the amount of diluent is calculated. Monitoring of patients with a should include repeated neurologic and hemodynamic assessment.
